Table 1.

HeV and NiV serum neutralization titers in vaccinated AGMs. Reciprocal serum dilution at which 50% of virus was neutralized.

		Day*
sGHeV doses (μg)	AGM	−42	−7	7	14	28	−42	−7	7	14	28
		HeV					NiV
0†	9	<20	<20	24	‡	‡	<20	<20	<20	‡	‡
10	16	<20	>2560	>2560	>2560	1074	<20	379	226	>2560	2147
	17	<20	>2560	>2560	905	537	<20	134	134	537	453
	18	<20	>2560	>2560	453	537	<20	189	134	189	453
50	13	<20	>2560	>2560	>2560	757	<20	379	189	189	453
	14	<20	1514	>2560	>2560	537	<20	28	47	226	134
	15	<20	2147	757	>2560	905	<20	67	95	757	1074
100	10	<20	>2560	2147	1810	453	<20	67	113	268	453
	11	<20	>2560	>2560	>2560	1514	<20	134	189	905	1514
	12	<20	>2560	>2560	>2560	757	<20	189	226	>2560	1514

^*Day after NiV challenge.

^†Received adjuvant alone.

^‡Not sampled; shading indicates increase in serum neutralization titer.